420 likes | 874 Views
A CPMC Regional CME Event. INFECTIOUS DISEASE Update. - Microbiome and Emerging Infections. Saturday October 19, 2013. HPV UPDATE: Head and neck Carcinoma. Gerald Kangelaris, MD San Francisco Otolaryngology. No Financial Disclosures. HPV In the media. HPV In the media.
E N D
A CPMC Regional CME Event INFECTIOUS DISEASE Update - Microbiome and Emerging Infections Saturday October 19, 2013
HPV UPDATE:Head and neck Carcinoma Gerald Kangelaris, MD San Francisco Otolaryngology
Goals Describe HPV associated head & neck cancer Understand at-risk population Appreciate disease presentation Describe basics of treatment and outcomes Improve ability to counsel patients!
OUTLINE – hpv in head & neck carcinoma Virology Epidemiology Carcinogenesis Presentation Treatment & Outcomes Future Directions
Virology http://hpvvirusinwomen.com/images/hpv_virus_in_women3.jpg • HPV • dsDNA virus • 100+ strains isolated • 15 strains high risk • Types 16 & 18 • Genitals • Anus • Oropharynx
Virology http://faculty.ksu.edu.sa/dralghamdi/Pictures%20Library/طبقات%20الجلد%20skin%20layers.jpg
Virology http://upload.wikimedia.org/wikipedia/commons/b/b4/Normal_Epidermis_and_Dermis_with_Intradermal_Nevus_10x.JPG http://www.lab.anhb.uwa.edu.au/mb140/corepages/Lymphoid2/images/tns02he.jpg
Virology http://www.region3sweetadelines.org/documents/AIM%202011/pharynx.jpg • Head & Neck Sites • Palatine tonsil • Tongue base
epidemiology D’Souza G, Kreimer A, et al. Case-Control Study of Human Papillomavirus and Oropharyngeal Cancer. N Eng J Med 2007, 356:1944-56.
epidemiology ChaturvediAK, Engels EA, et al. Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States. J ClinOnc2011. 29(32):4294-4301. • Head and Neck Cancers • Overall decreasing • Oropharynx increasing • OP Cancer Epidemic • OP HPV (-) • 2.0 1.0 per 100,000 • OP HPV (+) • 0.8 2.6 per 100,000
epidemiology http://quittea.com/wp-content/uploads/2012/06/Old-Guy-Smoking-Cigar.jpg http://i.telegraph.co.uk/multimedia/archive/01589/Lorna-Gobey_1589754c.jpg Typical Head & Neck Cancer Patient
epidemiology http://maennling.com/wp/wp-content/uploads/2012/11/DSC_6796.jpg http://ak9.picdn.net/shutterstock/videos/4194004/preview/stock-footage-smart-caucasian-middle-aged-man-looking-to-the-camera-in-the-park-close-up-portrait.jpg HPV Oropharynx Cancer Patient
epidemiology Gillison ML, Broutian T, et al. Prevalence of Oral HPV Infection in the United States, 2009-2010. J Am Med Assoc2012. 307(7):693-703. HPV (+) OPSCC as Sexually Transmitted Disease • Presence of HPV in Oral Samples Increases With… • Being sexually active • Early age sexual activity • Increasing # oral sex partners • Increasing # vaginal & anal sex partners • Male • No difference if hetero- or homosexual/bisexual
epidemiology Gillison ML, Broutian T, et al. Prevalence of Oral HPV Infection in the United States, 2009-2010. J Am Med Assoc2012. 307(7):693-703. HPV (+) OPSCC as Sexually Transmitted Disease Presence of HPV in Oral Samples…
epidemiology D’Souza G, Kreimer A, et al. Case-Control Study of Human Papillomavirus and Oropharyngeal Cancer. N Eng J Med 2007, 356:1944-56. HPV (+) OPSCC as Sexually Transmitted Disease • HPV (+) vs. HPV (-) OPSCC • Lifetime # Oral Sex Partners • 0 partners OR 1.0 • 1-5 partners OR 3.8 • 6+ partners OR 8.6 • Lifetime # Vaginal Sex Partners • 0-5 partners OR 1.0 • 6-25 partners OR 2.7 • 26+ partners OR 4.2
Carcinogenesis • Six non-structural proteins • Two viral oncoproteins E6 and E7 • E6 and E7 increased activity in high-risk HPV strains http://img.medscape.com/fullsize/migrated/585/223/erm585223.fig2.jpg • HPV DNA • Two capsid proteins, L1 and L2
Carcinogenesis • E6 • Degradation of tumor suppressor p53 • Prevents apoptosis • E7 • Loss of retinoblastoma (Rb) tumor suppressor • Accumulates p16 • Pushes cells from G1 S phase
presentation http://www.nidcr.nih.gov/NR/rdonlyres/04B2E6CA-B032-47C0-BC09-D995D6655AA6/18010/OralCancerFig14High.jpg Palatine or Lingual Tonsil Location
presentation • Symptoms • Painful oral lesion • Dysphagia or odynophagia • Bleeding • Asymmetry • Trismus • Otalgia • Hypoesthesia • Asymptomatic!
presentation http://www.ghorayeb.com/files/carcinoma_of_tonsil.jpg
presentation http://www.ghorayeb.com/files/Tongue_Sq_Cell_Ca_700_x_500.jpg
presentation • Differential Diagnosis • Infectious • Benign lesions • Neoplastic • Inflammatory
presentation http://quebal.icebergcms.com.au/images/product/image/enl_who_circumvallate_papillae.jpg
presentation http://www.capedental.com/cdmain/wp-content/uploads/2011/05/IMG_3641.jpg
presentation http://www.aafp.org/afp/2002/0901/afp20020901p831-f3.jpg http://1.bp.blogspot.com/-wotdvG47uXI/T3DkTZOhIZI/AAAAAAAAKPQ/ujuwutpvCyo/s1600/CysticNodesHPV.JPG • High Rates Nodal Metastases • Often Tumor Undetectable at Primary Site
presentation • Consider HPV(+) OPSCC • Neck mass persisting for 4+ weeks, unresponsive to medical therapy • Upper jugular chain • Firm, discrete, mobile, nontender • May be asymptomatic & non-visible at primary site! • Persistent OP sore throat 4+ weeks, unresponsive to medical therapy • Tonsillar asymmetry, otalgia • Advanced disease • Dysphagia, pharyngeal bleeding, trismus, voice changes
presentation • Workup • FNA neck mass • US guidance may improve yield in cystic masses • Imaging • Contrast enhanced CT / MRI neck • CXR • OHNS evaluation • Fiberopticnasopharyngoscopy • Exam under anesthesia, biopsies
TREATMENT & OUTCOME • Treatment Options • Concurrent chemoradiation • Surgery with adjuvant radiation, +/- chemotherapy
TREATMENT & OUTCOME Improved survival in HPV (+) OPSCC tumors Ang KK, Harris J, et al. Human Papillomavirus and Survival of Patients with OropharyngealCancer.NEng J Med 2010. 363(1):24-35.
TREATMENT & OUTCOME O’Rorke MA, Ellison MV, et al. Human Papillomavirus Related Head and Neck Cancer Survival: A Systematic Review and Meta-Analysis. Oral Oncology 2012. 48:1191-1201. • Improved survival in HPV (+) OPSCC tumors • 53% better overall survival • 74% better disease specific survival • Improvements in progression free survival, disease free survival
TREATMENT & OUTCOME • Mechanisms for Improved Outcomes • Lack of field cancerization • Increased sensitivity to radiation therapy • Degraded wild-type p53, not mutations • Immune response
Future directions • De-intensification strategies • Lower dose of radiation therapy • Targeted chemotherapeutics • Surgery with de-escalation of adjuvant treatment http://www.healthspablog.org/wp-content/uploads/2010/11/radiotherapy-6D.jpg http://oralcancernews.org/wp/wp-content/uploads/2011/09/robotic_surgery03.jpg
Future directions Vaccination http://www.pulsetoday.co.uk/Pictures/web/d/v/a/Cervarix_vaccine_pack_hpv_cervical.jpg http://www.thedailysheeple.com/wp-content/uploads/2012/10/GARDASIL111308.jpg
Future directions Vaccination http://www.skepticalraptor.com/blog/wp-content/uploads/2012/10/gardasil-ad1.jpg http://1.bp.blogspot.com/-ejglTzhvHAg/T6CydnVyaxI/AAAAAAAAAOs/pGVsBwnF3Pw/s1600/new%2Bdoc_1.jpg
Future directions Vaccination http://1.bp.blogspot.com/-0DPj7SzNye0/TzW3wpLXojI/AAAAAAAAB_I/DkBrrVtXdfA/s400/gardasil4-1.jpg http://gaia-health.com/gaia-blog/wp-content/uploads/2012/11/Say-No-to-Cervarix-and-Gardasil.jpg